Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Interferon β 1a

Interferon β 1a Reactions 1680, p184 - 2 Dec 2017 Psoriasis flare and Koebner phenomenon along abdominal injection site: case report A 26-year-old woman developed psoriasis flare and Koebner phenomenon along abdominal injection site during treatment with interferon β 1a [dosage and duration of treatment to reaction onset not stated]. The woman had a history of psoriasis. Subsequently, she was diagnosed with relapsing-remitting multiple sclerosis (RRMS). As a result, she received SC injection of interferon β 1a as first-line treatment for RRMS. However, four months after the initiation, the woman’s interferon β 1a therapy was switched to oral dimethyl fumarate due to the psoriasis flare with plaques in the upper and lower extremities. Additionally, she developed Koebner phenomenon at abdominal injection sites. Within 14 months of the initiation of dimethyl fumarate, a complete remission in her psoriatic eruptions was observed along with a residual discolouration in former Koebner-positive sites. From the last 3 years, she had been receiving dimethyl fumarate without any further relapse in multiple sclerosis. Author comment: "Interferon-induced psoriasis flare in a multiple sclerosis case remits with dimethyl fumarate." "Interferon was discontinued 4 months later, following a dramatic psoriasis flare with plaques in upper and lower extremities and manifestation of http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Interferon β 1a

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017

Interferon β 1a

Abstract

Reactions 1680, p184 - 2 Dec 2017 Psoriasis flare and Koebner phenomenon along abdominal injection site: case report A 26-year-old woman developed psoriasis flare and Koebner phenomenon along abdominal injection site during treatment with interferon β 1a [dosage and duration of treatment to reaction onset not stated]. The woman had a history of psoriasis. Subsequently, she was diagnosed with relapsing-remitting multiple sclerosis (RRMS). As a result, she received SC injection of...
Loading next page...
 
/lp/springer_journal/interferon-1a-kenJmys1Ov

References (1)

Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
DOI
10.1007/s40278-017-39115-8
Publisher site
See Article on Publisher Site

Abstract

Reactions 1680, p184 - 2 Dec 2017 Psoriasis flare and Koebner phenomenon along abdominal injection site: case report A 26-year-old woman developed psoriasis flare and Koebner phenomenon along abdominal injection site during treatment with interferon β 1a [dosage and duration of treatment to reaction onset not stated]. The woman had a history of psoriasis. Subsequently, she was diagnosed with relapsing-remitting multiple sclerosis (RRMS). As a result, she received SC injection of interferon β 1a as first-line treatment for RRMS. However, four months after the initiation, the woman’s interferon β 1a therapy was switched to oral dimethyl fumarate due to the psoriasis flare with plaques in the upper and lower extremities. Additionally, she developed Koebner phenomenon at abdominal injection sites. Within 14 months of the initiation of dimethyl fumarate, a complete remission in her psoriatic eruptions was observed along with a residual discolouration in former Koebner-positive sites. From the last 3 years, she had been receiving dimethyl fumarate without any further relapse in multiple sclerosis. Author comment: "Interferon-induced psoriasis flare in a multiple sclerosis case remits with dimethyl fumarate." "Interferon was discontinued 4 months later, following a dramatic psoriasis flare with plaques in upper and lower extremities and manifestation of

Journal

Reactions WeeklySpringer Journals

Published: Dec 2, 2017

There are no references for this article.